RICKLES RONALD L

Director · TNL

As of 2026-09-16, RICKLES RONALD L has 11 Form 4 transactions on record across 1 company — 5 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $3.5MIndirect: $0$3.5Mas of 2026-09-16
  • Direct $3.5M
  • Indirect $0
TNLdirect53,558 sh$3.5M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

TNL · 11 trades
2026-03-31: Award / grant, 488 sh ($0)2026-03-11: Award / grant, 3,653 sh ($0)2026-03-10: Award / grant, 1,328 sh ($0)2025-12-31: Award / grant, 406 sh ($0)2025-09-30: Award / grant, 445 sh ($0)2025-06-30: Award / grant, 507 sh ($0)2025-04-24: Award / grant, 531 sh ($0)2025-03-15: Award / grant, 2,859 sh ($0)2025-03-10: Award / grant, 1,787 sh ($0)2025-03-05: Award / grant, 4,767 sh ($0)2025-02-20: Award / grant, 361 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
11 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-03-31TNLAward / grant48853,558Form 4
2026-03-11TNLAward / grant3,65353,070Form 4
2026-03-10TNLAward / grant1,32849,417Form 4
2025-12-31TNLAward / grant40648,089Form 4
2025-09-30TNLAward / grant44547,683Form 4
2025-06-30TNLAward / grant50747,238Form 4
2025-04-24TNLAward / grant53146,731Form 4
2025-03-15TNLAward / grant2,85946,200Form 4
2025-03-10TNLAward / grant1,78743,341Form 4
2025-03-05TNLAward / grant4,76741,554Form 4
2025-02-20TNLAward / grant36136,787Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.